JONATHAN COAKHAM: Open Payments
NPI 1669034872 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 114 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,478 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $410 |
| Janssen Pharmaceuticals, Inc | 20 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $279 |
| ABBVIE INC. | 19 | $264 |
| Alkermes, Inc. | 7 | $158 |
| Otsuka America Pharmaceutical, Inc. | 9 | $137 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| Lundbeck LLC | 6 | $116 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, SPRAVATO, ARISTADA, REXULTI, ABILIFY ASIMTUFII, Auvelity.
Industry payments across NC — which companies pay providers there.
